Current Studies

Disclaimer: Every study has specific inclusion and exclusion criteria required to participate. Eligibility will be determined during screening process.

Healthy Subjects with Mild Asthma


An investigational study to test the safety of a commonly prescribed oral medication that is being evaluated in an inhaled form

  • Ages 18 – 55 years old 
  • Healthy by medical history and physical exam
  • Using one or more of the following asthma medications:
    • Albuterol Rescue Inhaler
    • Singulair (Montelukast)
    • Inhaled Steroid at a low dose (Flovent, QVAR, Pulmicort, Asmanex, or Arnuity)
  • NOT using any other daily medications (birth control & hormone replacement are allowed)
  • Normal height to weight ratio (BMI 18-35)
  • Non-smokers

*Additional criteria may apply

Study involves a 5-day and 5-night stay at the research site (24/7). Private room with WIFI plus meals provided. Drug, tobacco, and alcohol testing conducted. Compensation for a qualified subject is up to $2500. 

Asthma


Asthma study for subjects currently using Nucula or Fasenra as part of their asthma treatment

  • Ages 12 years old & Up 
  • Currently using a daily maintenance inhaler
  • Everyone receives active study medication
  • Non-smokers
  • Willing to complete 15 visits over 15 months
  • Study related care and study medication at no cost
  • Compensation for qualified participants is up to $1710

Asthma


 Asthma study evaluating a new combination inhaler

  • Ages 12 – 80 years old
  • Currently using a daily maintenance inhaler
  • Everyone receives active study medication
  • Non-smokers
  • Willing to complete 15 visits over 28 – 52 weeks
  • Study related care and study  medication at no cost
  • Compensation for qualified participants is $1500-$2300

Asthma


Adult asthma study evaluating a new “Add on” inhaler

  • Ages 18 – 75 years old
  • Non-smokers
  • Study medication is an “Add On” inhaler
  • Participants will remain on their current maintenance inhaled steroid treatment
  • Willing to complete 11 visits over 30 weeks
  •  Study related care and study medication at no cost
  • Compensation for qualified participants is up to $1760

Asthma


Adult asthma study evaluating a new “Add on” inhaler

  • Ages 18 years old & up 
  • Non-smokers
  • Willing to complete 10 visits over 24 weeks
  • Study related care and study medication at no cost
  • Compensation for qualified participants is up to $1405

Asthma


Adult asthma study evaluating a new “Add On” medication

  • Ages 18 years old and up
  • Non-smoker
  • Willing to complete 10 visits over 34 weeks
  • Study related care and study medication at no cost
  • Compensation for qualified participants is up to $1225

Pediatric Asthma


Pediatric asthma study evaluating two FDA approved inhalers

  • Ages 5 – 11 years old
  • 8 morning visits over 7 months
  • Currently using maintenance inhaled steroid
  • Must be average height and weight percentile
  • Study related care and study medications at no cost
  • NO chance of placebo in this study
  • Compensation for qualified participants is up to $960

Celiac Disease – Part A

Participate in Part A or B, but not both


An Investigational medication designed to re-educate the immune system of celiac patients so it no longer reacts to a gluten.

  • Ages 18 – 70 years old
  • Biopsy Confirmed Celiac Disease
  • On gluten-free diet for at least the last 12 months
  • Everyone receives active study medication
  • Willing to complete 5 visits over 49 days
  • Study related care and study medication at no cost
  • Compensation for qualified participants is up to $720

Celiac Disease – Part B

Participate in Part A or B, but not both


An Investigational medication designed to re-educate the immune system of celiac patients so it no longer reacts to gluten.

  • Ages 18 – 70 years old
  • Biopsy Confirmed Celiac Disease
  • On gluten-free diet for at least the last 12 month
  • Willing to complete 6 visits over 56 days and a gluten challenge
  • Study related care and study medication at no cost
  • Compensation for qualified participants is up to $2074